The novel treatment of the medication represents a major breakthrough in the care of the condition. Distinct from existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide845843.myparisblog.com/42565089/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment